Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 16.14 is 746% above its 4-year average of 1.91, near the high end of its 4-year range (0.00–17.51).
As of the fiscal period ended Tuesday, June 30, 2026. 67.55% above its 12-month average of 9.63.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.14.
QUICK RATIO (ACID-TEST)
16.14
QUICK RATIO (ACID-TEST) AVG TTM
9.63
QUICK RATIO (ACID-TEST) AVG 3Y
3.89
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+67.55%
CURRENT VS 3Y AVG
+314.96%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+381.13%
vs the sector median at left
Telomir Pharmaceuticals, Inc. Common Stock
Market Cap
$82.53M
Quick Ratio (Acid-Test)
16.14
TTM Avg
9.63
3Y Avg
3.89
5Y Avg
N/A
Market Cap
$82.47M
Quick Ratio (Acid-Test)
3.30
TTM Avg
5.38
3Y Avg
8.10
5Y Avg
12.75
Market Cap
$82.59M
Quick Ratio (Acid-Test)
7.85
TTM Avg
4.70
3Y Avg
2.98
5Y Avg
5.25
Market Cap
$81.22M
Quick Ratio (Acid-Test)
8.75
TTM Avg
11.02
3Y Avg
14.04
5Y Avg
18.21
Market Cap
$81.20M
Quick Ratio (Acid-Test)
4.02
TTM Avg
5.44
3Y Avg
3.75
5Y Avg
3.66
Market Cap
$84.13M
Quick Ratio (Acid-Test)
7.03
TTM Avg
3.05
3Y Avg
3.90
5Y Avg
4.20
Market Cap
$80.30M
Quick Ratio (Acid-Test)
5.74
TTM Avg
2.67
3Y Avg
4.44
5Y Avg
7.03
Market Cap
$79.61M
Quick Ratio (Acid-Test)
7.99
TTM Avg
9.12
3Y Avg
12.06
5Y Avg
14.25
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $82.53M | 16.14 | 9.63 | 3.89 | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | 3.30 | 5.38 | 8.10 | 12.75 |
| ProMIS Neurosciences, Inc. (PMN)vs › | $82.59M | 7.85 | 4.70 | 2.98 | 5.25 |
| LENSAR Inc (LNSR)vs › | $82.29M | 1.13 | 1.33 | 1.81 | 2.82 |
| MediciNova, Inc. (MNOV)vs › | $81.22M | 8.75 | 11.02 | 14.04 | 18.21 |
| Nutriband Inc. (NTRB)vs › | $81.20M | 4.02 | 5.44 | 3.75 | 3.66 |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | 7.03 | 3.05 | 3.90 | 4.20 |
| Humacyte, Inc. (HUMA)vs › | $80.30M | 5.74 | 2.67 | 4.44 | 7.03 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | 7.99 | 9.12 | 12.06 | 14.25 |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $85.86M | 7.70 | 11.16 | 14.97 | 23.58 |
Quick Ratio
16.14
Excludes inventory
Current Ratio
16.14
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 16.14 |
| 2026-03-31 | 7.00 |
| 2025-12-31 | 5.14 |
| 2025-09-30 | 17.51 |
| 2025-06-30 | 2.38 |
| 2025-03-31 | 0.75 |
| 2024-12-31 | 1.94 |
| 2024-09-30 | 1.74 |
| 2024-06-30 | 3.93 |
| 2024-03-31 | 7.20 |
| 2023-12-31 | 0.33 |
| 2023-09-30 | 0.08 |
| 2023-06-30 | 0.05 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.00 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
